Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Melissa K Carpenter"'
Autor:
Suzanne E Peterson, Jurjen W Westra, Stevens K Rehen, Holly Young, Diane M Bushman, Christine M Paczkowski, Yun C Yung, Candace L Lynch, Ha T Tran, Kyle S Nickey, Yu-Chieh Wang, Louise C Laurent, Jeanne F Loring, Melissa K Carpenter, Jerold Chun
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e23018 (2011)
Human pluripotent stem cell (hPSC) lines have been considered to be homogeneously euploid. Here we report that normal hPSC--including induced pluripotent--lines are karyotypic mosaics of euploid cells intermixed with many cells showing non-clonal ane
Externí odkaz:
https://doaj.org/article/d2ba257e2f15481f86a4b1b0c20a9ba5
Autor:
Melissa K Carpenter
Publikováno v:
Cell and Gene Therapy Insights. 8:39-41
Autor:
Fuchou Tang, Insoo Hyun, Azim Surani, Julie Steffann, Ellen Wright Clayton, Lori R. Hill, Xiaomei Zhai, Jin-Soo Kim, Nicolas C. Rivron, Ali H. Brivanlou, Melissa K. Carpenter, Steve A. Goldman, Roger A. Pedersen, Jonathan Kimmelman, Mitinori Saitou, Jeff Round, Jürgen A. Knoblich, Misao Fujita, Hiromitsu Nakauchi, Kathy K. Niakan, Amander T. Clark, Gail Naughton, Luigi Naldini, Janet Rossant, R. Alta Charo, Debra J. H. Mathews, Roger A. Barker, Patricia J. Zettler, Tania Bubela, Kazuto Kato, Ubaka Ogbogu, Andy Greenfield, George Q. Daley, Leigh Turner, Megan Munsie, Eric Anthony, Heather M. Rooke, Nuria Montserrat, Yali Cong, Jeremy Sugarman, Jianping Fu, Douglas Sipp, Jeffrey P. Kahn, Jun Takahashi, Robin Lovell-Badge, Jack Mosher, Rosario Isasi
Publikováno v:
Stem cell reports, vol 16, iss 6
Lovell-Badge, R, Anthony, E, Barker, R A, Bubela, T, Brivanlou, A H, Carpenter, M, Charo, R A, Clark, A, Clayton, E, Cong, Y, Daley, G Q, Fu, J, Fujita, M, Greenfield, A, Goldman, S A, Hill, L, Hyun, I, Isasi, R, Kahn, J, Kato, K, Kim, J S, Kimmelman, J, Knoblich, J A, Mathews, D, Montserrat, N, Mosher, J, Munsie, M, Nakauchi, H, Naldini, L, Naughton, G, Niakan, K, Ogbogu, U, Pedersen, R, Rivron, N, Rooke, H, Rossant, J, Round, J, Saitou, M, Sipp, D, Steffann, J, Sugarman, J, Surani, A, Takahashi, J, Tang, F, Turner, L, Zettler, P J & Zhai, X 2021, ' ISSCR Guidelines for Stem Cell Research and Clinical Translation : The 2021 update ', Stem Cell Reports, vol. 16, no. 6, pp. 1398-1408 . https://doi.org/10.1016/j.stemcr.2021.05.012
Stem Cell Reports
Lovell-Badge, R, Anthony, E, Barker, R A, Bubela, T, Brivanlou, A H, Carpenter, M, Charo, R A, Clark, A, Clayton, E, Cong, Y, Daley, G Q, Fu, J, Fujita, M, Greenfield, A, Goldman, S A, Hill, L, Hyun, I, Isasi, R, Kahn, J, Kato, K, Kim, J S, Kimmelman, J, Knoblich, J A, Mathews, D, Montserrat, N, Mosher, J, Munsie, M, Nakauchi, H, Naldini, L, Naughton, G, Niakan, K, Ogbogu, U, Pedersen, R, Rivron, N, Rooke, H, Rossant, J, Round, J, Saitou, M, Sipp, D, Steffann, J, Sugarman, J, Surani, A, Takahashi, J, Tang, F, Turner, L, Zettler, P J & Zhai, X 2021, ' ISSCR Guidelines for Stem Cell Research and Clinical Translation : The 2021 update ', Stem Cell Reports, vol. 16, no. 6, pp. 1398-1408 . https://doi.org/10.1016/j.stemcr.2021.05.012
Stem Cell Reports
Summary The International Society for Stem Cell Research has updated its Guidelines for Stem Cell Research and Clinical Translation in order to address advances in stem cell science and other relevant fields, together with the associated ethical, soc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9679b99baff81140258dc68acd81d0b
https://escholarship.org/uc/item/6v72c60f
https://escholarship.org/uc/item/6v72c60f
Autor:
Mark C. Poznansky, Thierry Berney, Luhan Yang, Jon S. Odorico, Melanie L. Graham, Julia L. Greenstein, Lorenzo Piemonti, Bart O. Roep, Melissa K. Carpenter, Kevin A. D'Amour, Chad A. Cowan, Jose Oberholzer, C Ricordi, Alice A. Tomei, James F. Markmann, Ludovic Vallier, Albert Hwa, Dieter Egli, Giuseppe Orlando, Ali Naji, Michael R. Rickels, Giovanni Migliaccio, Shane T. Grey, Bernhard J. Hering, Thomas W.H. Kay, Dale L. Greiner, Ann Jensen Adams, Cristina Nostro, Barbara Ludwig, Qizhi Tang, Alireza Rezania, Daniel Pipeleers, Danwei Huangfu, Uri Ben-David, Douglas A. Melton, Daniel G. Anderson
Publikováno v:
Transplantation
Transplantation (2018)
Transplantation, 102(8), 1223-1229
Transplantation, vol 102, iss 8
Transplantation (2018)
Transplantation, 102(8), 1223-1229
Transplantation, vol 102, iss 8
Beta cell replacement has the potential to restore euglycemia in patients with insulin dependent diabetes. While great progress has been made in establishing allogeneic islet transplantation from deceased donors as the standard of care for those with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67f5df07c7122eecb6ecd7e2a579770e
https://hdl.handle.net/1887/87310
https://hdl.handle.net/1887/87310
Autor:
Catriona Jamieson, Roger A. Barker, Charles E. Murry, Melissa K. Carpenter, Steven A. Goldman, Jun Takahashi, Stuart J. Forbes, Gordon C. Weir
Publikováno v:
Barker, R A, Carpenter, M K, Forbes, S, Goldman, S A, Jamieson, C, Murry, C E, Takahashi, J & Weir, G 2018, ' The Challenges of First-in-Human Stem Cell Clinical Trials : What Does This Mean for Ethics and Institutional Review Boards? ', Stem Cell Reports, vol. 10, no. 5, pp. 1429-1431 . https://doi.org/10.1016/j.stemcr.2018.04.010
Stem Cell Reports
Stem Cell Reports, Vol 10, Iss 5, Pp 1429-1431 (2018)
Stem Cell Reports
Stem Cell Reports, Vol 10, Iss 5, Pp 1429-1431 (2018)
Stem cell-based clinical interventions are increasingly advancing through preclinical testing and approaching clinical trials. The complexity and diversity of these approaches, and the confusion created by unproven and untested stem cell-based “the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b014102f92550138fe685c8d81378075
https://www.pure.ed.ac.uk/ws/files/64211499/1_s2.0_S2213671118301784_main.pdf
https://www.pure.ed.ac.uk/ws/files/64211499/1_s2.0_S2213671118301784_main.pdf
Autor:
Melissa K. Carpenter, Larry A. Couture
Publikováno v:
Stem Cells Translational Medicine. 4:1097-1100
Summary Several human embryonic stem cell (hESC)-derived cell therapeutics have entered clinical testing and more are in various stages of preclinical development. The U.S. Food and Drug Administration (FDA) regulates these products under existing re
Autor:
Melissa K. Carpenter
The development of pluripotent stem cell (PSC) therapies is rapidly advancing, and a number of PSC-derived cell products are currently being tested in clinical trials. The biological complexity of these therapies results in specific challenges in com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a991761cae8e949e199c0f90ef3434d
https://doi.org/10.1016/bs.pbr.2016.12.008
https://doi.org/10.1016/bs.pbr.2016.12.008
Publikováno v:
Nature Biotechnology. 27:606-613
Translation of human pluripotent stem cells into cell therapies will require the development of standardized tests for product consistency, stability, tumorigenicity, toxicity and immunogenicity.
Autor:
Justine J Cunningham, Mike Richardson, Kuniko Kadoya, Nora G. Smart, Melissa K. Carpenter, Susan Eliazer, Holly Y. Young, Emmanuel E. Baetge, Anne G. Bang, Olivia Kelly, Evert Kroon, Alan D. Agulnick, Laura Martinson, Kevin A. D'Amour
Publikováno v:
Nature Biotechnology. 26:443-452
Development of a cell therapy for diabetes would be greatly aided by a renewable supply of human β-cells. Here we show that pancreatic endoderm derived from human embryonic stem (hES) cells efficiently generates glucose-responsive endocrine cells af
Autor:
Julian Hitchcock, James Lawford Davies, Christopher E. Mason, J. Mason, Melissa K. Carpenter, Emily J. Culme-Seymour
Publikováno v:
Regenerative medicine. 10(5)